Veradermics Common stock, shares authorized (in shares) decreased by 25.2% to 200M in Q1 2026 compared to the prior quarter.
An increase indicates that shareholders have approved a higher ceiling for potential future equity issuance, often for capital raises or stock-based compensation.
This represents the maximum number of common shares that a corporation is legally permitted to issue under its articles...
Standard corporate governance metric; companies often maintain a buffer between authorized and outstanding shares.
other_common_stock_shares_authorized| Q2 '23 | Q4 '24 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | 18M | 98.8M | 267.5M | 200M |
| QoQ Change | — | +448.7% | +170.8% | -25.2% |
| YoY Change | — | — | +170.8% | — |